Gibson Christopher

CIK 00018563691 companySALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001856369

Recent Transactions

50 trades

Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-20+40,000→ 953,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-01-20−40,000→ 4,623,334 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-20$4.47/sh−40,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-01-05−60,000→ 4,663,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-05+60,000→ 973,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-05$4.25/sh−40,000→ 933,839 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-05−20,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-19+40,000→ 953,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-12-19−40,000→ 4,723,334 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-19$4.50/sh−40,000→ 913,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04$4.63/sh−40,000→ 933,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04+60,000→ 973,839 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04−20,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-12-04−60,000→ 4,763,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-11-19−40,000→ 4,823,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-19+40,000→ 953,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-19$4.16/sh−40,000→ 913,839 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-17$4.14/sh−40,390→ 913,839 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-04−20,000→ 954,229 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-04$5.21/sh−40,000→ 974,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-11-04−60,000→ 4,863,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-04+60,000→ 1,014,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-23+100,000→ 1,054,229 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-23$5.70/sh−100,000→ 954,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-10-23−100,000→ 4,923,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-10+120,000→ 1,074,229 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-10−20,000→ 954,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-10-10−120,000→ 5,133,034 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-10$6.04/sh−100,000→ 974,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-09-25−0→ 5,253,034 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-09-25+100,000→ 1,054,229 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-09-25$4.76/sh−100,000→ 954,229 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-09-10$4.71/sh−100,000→ 974,229 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-09-10−20,000→ 954,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-09-10−120,000→ 5,253,034 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-09-10+120,000→ 1,074,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-08-26−100,000→ 5,373,034 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-26$4.84/sh−100,000→ 954,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-26+100,000→ 1,054,229 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-15$5.64/sh−40,390→ 954,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-11+17,875→ 17,875 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-08-11−423,666→ 5,473,034 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-11+423,666→ 1,504,919 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-11$5.28/sh−17,875→ 0 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-08-11−100,000→ 386,000 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-11−10,000→ 994,619 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-11+100,000→ 100,000 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-11$5.28/sh−500,300→ 1,004,619 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-11$5.28/sh−100,000→ 0 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-08-11−17,875→ 50,000 total

Companies

RECURSION PHARMACEUTICALS, INC.
Director
$RXRX

Recent Filings

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101

View on SEC.gov